Literature DB >> 30029014

Pathogenicity and cross-reactive immune responses of a historical and a contemporary Senecavirus A strains in pigs.

Maureen H V Fernandes1, Mayara F Maggioli1, Lok R Joshi1, Travis Clement2, Tatiane C Faccin3, Rolf Rauh4, Fernando V Bauermann1, Diego G Diel5.   

Abstract

The goals of this study were to compare the pathogenicity and infection dynamics of a historical and a contemporary SVA strains (SVV 001 and SD15-26) and to assess cross-neutralizing and cross-reactive T cell responses following experimental infection in pigs. Both SVA strains successfully infected all inoculated animals, resulting in viremia and robust antibody and cellular immune responses. SVA SD15-26 infection resulted in characteristic clinical signs and vesicular lesions, however, SVA SVV 001 did not cause overt clinical disease with inoculated animals remaining clinically normal during the experiment. Notably, neutralization- and -recall IFN-γ expression-assays revealed marked cross-neutralizing antibody and cross-reactive T cell responses between the two viral strains. Together these results demonstrate that the historical SVA SVV 001 strain presents low virulence in pigs when compared to the contemporary SVA SD15-26 strain. Additionally, immunological assays indicate that SVA SVV 001 and SD15-26 are antigenically related and share conserved antigenic determinants.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cross-immunity; Pathogenesis; Seneca Valley virus; Senecavirus A; Vesicular disease

Mesh:

Substances:

Year:  2018        PMID: 30029014     DOI: 10.1016/j.virol.2018.06.003

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Vesicular disease in pigs inoculated with a recent Canadian isolate of Senecavirus A.

Authors:  Kate Hole; Thanuja Ambagala; Charles Nfon
Journal:  Can J Vet Res       Date:  2019-10       Impact factor: 1.310

2.  Persistent Infection and Transmission of Senecavirus A from Carrier Sows to Contact Piglets.

Authors:  Mayara F Maggioli; Maureen H V Fernandes; Lok R Joshi; Bishwas Sharma; Megan M Tweet; Jessica C G Noll; Fernando V Bauermann; Diego G Diel
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

3.  The third wave of Seneca Valley virus outbreaks in pig herds in southern Brazil.

Authors:  Marcos V Vieira; Carolina Y Yasumitsu; Alais M Dall Agnol; Raquel A Leme; Alice F Alfieri; Amauri A Alfieri
Journal:  Braz J Microbiol       Date:  2022-05-12       Impact factor: 2.214

4.  Comparative Proteomic Analysis Reveals Mx1 Inhibits Senecavirus A Replication in PK-15 Cells by Interacting with the Capsid Proteins VP1, VP2 and VP3.

Authors:  Hang Gao; Zhaoying Xiang; Xinna Ge; Lei Zhou; Jun Han; Xin Guo; Yanhong Chen; Yongning Zhang; Hanchun Yang
Journal:  Viruses       Date:  2022-04-21       Impact factor: 5.818

5.  Senecavirus A 3C Protease Mediates Host Cell Apoptosis Late in Infection.

Authors:  Maureen H V Fernandes; Mayara F Maggioli; Jaelin Otta; Lok R Joshi; Steve Lawson; Diego G Diel
Journal:  Front Immunol       Date:  2019-03-13       Impact factor: 7.561

6.  A Novel Live Attenuated Vaccine Candidate Protects Against Heterologous Senecavirus A Challenge.

Authors:  Bishwas Sharma; Maureen H V Fernandes; Marcelo de Lima; Lok R Joshi; Steve Lawson; Diego G Diel
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

Review 7.  Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics.

Authors:  Virginia Corbett; Paul Hallenbeck; Piotr Rychahou; Aman Chauhan
Journal:  Front Mol Biosci       Date:  2022-08-26

8.  Comparison of the Pathogenicity of Two Different Branches of Senecavirus a Strain in China.

Authors:  Huawei Zhang; Pin Chen; Genxi Hao; Wenqiang Liu; Huanchun Chen; Ping Qian; Xiangmin Li
Journal:  Pathogens       Date:  2020-01-02

9.  Prolonged Viability of Senecavirus A in Exposed House Flies (Musca domestica).

Authors:  Justin Heath Turner; Willian Pinto Paim; Mayara Fernanda Maggioli; Cristina Mendes Peter; Robert Miknis; Justin Talley; Fernando Vicosa Bauermann
Journal:  Viruses       Date:  2022-01-11       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.